Dirk H. van den Eijnden serving as Executive Editors. Both the Editors and Board members were selected from all over the world, reflecting the international focus of the new journal. The first cover of the journal showed a Haworth Projection of a hexose enclosing an electron micrograph of the Golgi (Figure 1 , reproduced on the cover of this issue), reflecting the importance of this organelle in the biosynthesis of complex glycans. In the early 1990s, it became apparent to the Board of Directors of the Society for Complex Carbohydrates that the Society's name did not adequately reflect the new directions of the field into myriad diverse areas of biology. At the 22nd Annual Meeting (1993) in Puerto Rico, the membership nearly unanimously voted to both change the name of the Society to "Society for Glycobiology" and also to make Glycobiology the Society's official journal (Hart 1994) . By 1996, it was very clear that Glycobiology was not only the leading specialty journal in our field, but also that Glycobiology ranked highly in terms of its relative impact among all biochemical journals, only just behind Journal of Biological Chemistry and Journal of Molecular Biology but ahead of Proteins, Biochemistry, Biochemical Journal and European Journal of Biochemistry (Hart 1996) . Carrying the torch (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) Entering 2001, when Ronald Schnaar took over as Editor-in-Chief, the journal was a leader in its discipline with great momentum and a superb editorial board. The major challenge was to bring it quickly and fully into the digital age. With strong support from our publisher, Oxford University Press, electronic submission/review and rapid electronic publishing (Advance Access) were quickly realized. The first manuscript submitted electronically to Glycobiology was uploaded in November 2001 by an international collaboration of leaders in the field reporting the relationship between lipid-linked oligosaccharide metabolism and structure, ER stress and congenital disorder of glycosylation Type I (Schang et al. 2002) . It was fitting that this first electronically uploaded manuscript represented the intellectual and global breadth that the journal was seeking to foster. By 2003 manuscript submission was fully electronic, the turnaround time from acceptance to Advance Access upload (and PubMed indexing) was reduced to about a week and our relationship with HighWire press maintained high standards for online presentation of our work. Through consortium sales of online content and rapid distribution worldwide the influence of papers in Glycobiology grew, as did manuscript submissions. Annual citations of Glycobiology papers doubled, and throughout the rest of the decade web-based downloads of papers from the Glycobiology web site averaged about half a million a year. The international scope of Glycobiology was maintained as a high priority, with wonderfully broad global representation among Associate Editors and on the Editorial Board. Submissions to the journal during the decade were from 53 countries, with about 30% each from Asia, Europe and North America, and others from Australia, New Zealand, as well as several countries in South America and Africa. We had reached a goal of being globally accessible both as a submission site and access site for high-quality glycobiology research.
As Editor-in-Chief during this period, in addition to making the journal electronically accessible, Ron saw his mandate as maintaining the high quality that its founders and the Society had created since its inception. With knowledgeable and enthusiastic editors as well as excellent technical support, that goal was reached. His most enjoyable yearly tasks during his decade as Editor-in-Chief were the annual meetings of the Editorial Board, who continued to keep the journal on track, and choosing the cover art. From Vince Hascall's multicolor canvas of cellular hyaluronic acid to Jamie Marth's "starry night" of pancreatic β-cell glucose transporter, from Kelly Ten Hagen's GalNAcT's on Drosophila embryos to the many beautiful molecular models from around the world, it was his pleasure each year to look at glycobiology with an eye for beauty and style as well as science.
The present and into the future (2011-present and beyond) As Robert Haltiwanger took over as Editor-in-Chief in 2011, the goal was to maintain the excellent traditions begun by Hart and Schnaar, serving the Glycobiology community by providing a venue for publication of high-quality papers relevant to the field, publishing reviews of interest to those inside and outside the field and encouraging communication of items relevant to the field in Glyco-Forum including meeting announcements and summaries, brief technical comments, letters and notification of significant events (awards, obituaries). The submission and review process has continued to be refined and accelerated: the current average time to first decision on a submitted manuscript is 19 days, and the average time for an accepted manuscript to appear online is less than 1 week. In an effort to reach out to and highlight specific scientific communities under the Glycobiology umbrella, the journal has recently published a number of Special Issues that include several reviews on a related topic. All reviews in Special Issues are freely available to the scientific community. Four Special Issues have been published to date:
In addition, the journal has recently begun to encourage submission of manuscripts from the broad areas covered by the field, including analytical glycobiology, cancer biology, cell biology, computational biology, chemical biology, genetic disorders of glycosylation, developmental biology, glycan synthesis, glycan metabolism, glycan recognition, immunology, microbial biology, neurobiology, plant biology, structural biology, systems biology, translational glycobiology and vascular biology. Authors can select which of these areas is most appropriate for their manuscript, and the articles published in each issue are grouped based on these categories.
The past 25 years have seen tremendous growth in the field of glycobiology, and the initial claims that glycans would impact all areas of biology have been confirmed many times over. The recent National Research Council Report, Transforming Glycoscience: A Roadmap for the Future (see Haltiwanger 2013) and the creation of the NIH Common Fund Glycoscience Program (https://commonfund.nih.gov/ Glycoscience) demonstrate the appreciation the larger scientific community now has for the importance of glycobiology. The goals of the journal have not changed from those described in the Jerry Hart's editorial in the first issue, "to promote quality science that contributes to a greater understanding of the biological properties and functions of glycoconjugates". We look forward to working with the field over the next 25 years to continue pursuing this goal.
